8-K: Twinlab Holdings Assigns Assets in Creditor Deal

Twinlab Consolidated Holdings, Inc. has filed for an assignment for the benefit of creditors, leading to the sale of its operating assets and brands to cbdMD, Inc. for $3.98 million.

Summary

• Twinlab Consolidated Holdings, Inc. (the Company) has entered into an assignment for the benefit of creditors (ABC) process for its subsidiaries TCC, THI, and OH.
• These subsidiaries held the Company's branded nutritional supplement operations, including Twinlab, Reserveage, Metabolife, and Alvita Tea brands, as well as the NutraScience Labs contract manufacturing business.
• The Company itself is not an assignor and did not make an assignment for the benefit of creditors.
• An Asset Purchase Agreement was entered into with cbdMD, Inc. (and its subsidiary To Be Brands, LLC) for the sale of specified assets of the assignment estates for a purchase price of $3,979,805.
• The purchase price consists of the assumption of $1,750,000 in secured indebtedness owed to Akretive Holdings, LLC and the issuance of 2,229,805 shares of cbdMD common stock to Akretive.
• No direct consideration is payable to the Company.
• The Company expects to deconsolidate the Assignors and their subsidiaries and anticipates no recovery for its common stockholders.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as highly negative, indicating a near-total cessation of operations for Twinlab Consolidated Holdings, Inc. through an assignment for the benefit of creditors and a subsequent asset sale, with no expected recovery for shareholders.

Positives

• The transaction provides a path for the continued availability of Twinlab's brands and products.
• The acquisition is expected to increase cbdMD's revenues to approximately $30 million, representing a 40% increase based on unaudited trailing twelve months of revenue.
• The acquisition diversifies cbdMD's revenue streams away from a concentration in the hemp category.

Negatives

• Twinlab Consolidated Holdings, Inc. has effectively ceased operations through its subsidiaries' assignment for the benefit of creditors.
• The Company's equity interests in the Assignors and related goodwill are considered impaired in full.
• The Company has no operating business and no remaining material assets, potentially becoming a shell company.
• Shareholders of Twinlab Consolidated Holdings, Inc. are not expected to receive any recovery.
• The Company is delinquent in its periodic reports with the SEC.

Risks

• The sale is subject to court approval, and the Assignee may receive or accept a higher and better offer.
• There is no assurance that cbdMD's stockholders will approve the issuance of shares as part of the purchase price.
• The Company has significant remaining obligations to Akretive Holdings, LLC.
• The Company is evaluating its alternatives, including its reporting obligations and ability to continue as a going concern.

Future Outlook

The Company expects to provide transition services to cbdMD on a cost-reimbursement basis. Its activities will primarily consist of fulfilling its remaining obligations under the Asset Purchase Agreement and Transition Services Agreement, and administering its remaining liabilities. The Company is evaluating its alternatives, including its reporting obligations and ability to continue as a going concern, and does not expect any surplus to be available for equity holders.

Management Comments

• "Twinlab is the kind of brand equity that companies spend decades trying to build," said Ronan Kennedy, CEO of cbdMD. "The brands, distribution channels, and team are highly complementary to what we already operate, and this transaction gives these brands the stability and support they need for their next chapter."
• "We believe there is a significant opportunity to build on cbdMDs revenue growth by applying our marketing, creative, and ecommerce resources to drive brand awareness and expand direct-to-consumer sales, alongside the strong wholesale and retail presence these brands already have."
• "Together, we will bring a uniquely complete wellness portfolio spanning foundational vitamins, minerals, and nutrition through botanicals, beauty, longevity, functional mushrooms, cannabinoids, and the emerging breakthroughs defining where this industry is headed. We believe no other company can serve consumers across more needs, more moments, and more stages of life than we now can together.", said Anthony Zolezzi, Chief Executive Officer of Twinlab.
• "This combination will pair decades of heritage and category credibility with a modern, marketing-driven platform and the resources to reintroduce these products to a new generation of consumers. It positions the brands, and the people behind them, for a strong future."

Industry Context

StockSavvy.ai notes that this transaction reflects a trend of established consumer wellness brands, particularly those facing financial distress or regulatory challenges (like Twinlab's legacy supplement business), being acquired by larger, more diversified companies (like cbdMD) seeking to expand their market reach and product portfolios. This allows the acquired brands to continue operating under new ownership with greater financial stability, while the acquiring company benefits from established brand recognition and market presence.

Comparison to Industry Standards

• The sale of assets through an assignment for the benefit of creditors is a common, albeit distressed, method for liquidating business assets when a company cannot meet its financial obligations. This process aims to maximize recovery for creditors under court supervision.
• The purchase price of $3.98 million for brands like Twinlab, Reserveage, and Metabolife, which have significant retail presence (50,000 outlets including Vitamin Shop and GNC) and Amazon presence, appears low relative to their historical brand value, but is constrained by the distressed nature of the sale and the significant secured debt owed to Akretive ($67.5 million).
• The structure of the deal, where the primary consideration goes to the secured creditor (Akretive) rather than the company or its shareholders, is typical in ABC proceedings where secured debt significantly outweighs asset value.
• cbdMD's strategy of acquiring established brands to diversify its revenue and reduce reliance on the hemp category aligns with broader industry consolidation and brand-building efforts in the consumer wellness space.

Legal Proceedings

• Assignment for the Benefit of Creditors proceedings filed in the Circuit Court of Broward County, Florida for Twinlab Consolidation Corporation, Twinlab Holdings, Inc., and Organic Holdings, LLC.

Related Party Transactions

• Akretive Holdings, LLC is the secured creditor of the Assignors and is receiving the majority of the purchase price consideration (debt assumption and cbdMD stock).

Stakeholder Impact

• Shareholders: No recovery expected for Twinlab Consolidated Holdings, Inc. shareholders.
• Creditors: Secured creditor Akretive Holdings, LLC will receive partial recovery through debt assumption and cbdMD stock. Other creditors of the Assignors will receive distributions based on statutory priority, with limited expectation of full recovery.
• Customers and Retailers: Products are expected to remain available, with a commitment from cbdMD for long-term support.
• Employees: The filing does not detail the impact on employees of the Assignors, though the Asset Purchase Agreement includes provisions for transition services and potential employment with cbdMD.

Next Steps

• Court approval of the sale by the ABC Court.
• Completion of the Asset Purchase Agreement, subject to closing conditions.
• cbdMD to provide transition services to the acquired business.
• Twinlab Consolidated Holdings, Inc. to evaluate its remaining obligations and reporting status.

Key Dates

Recommendation

The filing details a near-complete cessation of operations for Twinlab Consolidated Holdings, Inc. through an assignment for the benefit of creditors and a subsequent asset sale. The company has no operating business and no material assets remaining, with no expected recovery for shareholders. The significant debt burden and the nature of the transaction strongly indicate a complete loss for equity holders.

Keywords

assignment for benefit of creditors, asset purchase agreement, nutritional supplements, brand acquisition, debt restructuring, liquidation, sec filing, form 8-k